Key points are not available for this paper at this time.
For the first time in history, influenza vaccine could be available at the beginning of an influenza pandemic. This is the result of the removal of major technical barriers; however, political and economic hurdles remain. In this Policy Forum, the authors describe solutions outlined by the World Health Organization Influenza Programme for expediting progress and increasing market forces to develop influenza pandemic vaccines.
Stöhr et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: